Ann Thompson

2.4k total citations · 1 hit paper
21 papers, 2.0k citations indexed

About

Ann Thompson is a scholar working on Epidemiology, Immunology and Allergy and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ann Thompson has authored 21 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Immunology and Allergy and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ann Thompson's work include Allergic Rhinitis and Sensitization (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Ann Thompson is often cited by papers focused on Allergic Rhinitis and Sensitization (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Ann Thompson collaborates with scholars based in United States, Canada and United Kingdom. Ann Thompson's co-authors include Elizabeth F. Juniper, E. Jan Irvine, Qin Zhou, Jeremy Roberts, Penelope J. Ferrie, Eli O. Meltzer, Natalie B. Roberts, Derek King, William C. Howland and Bruce Crawford and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Allergy and Clinical Immunology and Critical Care Medicine.

In The Last Decade

Ann Thompson

20 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.

1996 529 citations Ann Thompson et al. profile →

Peers

Countries citing papers authored by Ann Thompson

Since Specialization

Citations

This map shows the geographic impact of Ann Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Thompson more than expected).

Fields of papers citing papers by Ann Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Thompson. The network helps show where Ann Thompson may publish in the future.

Co-authorship network of co-authors of Ann Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Thompson. A scholar is included among the top collaborators of Ann Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Thompson. Ann Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost–effectiveness analysis of Avance ^® allograft for the treatment of peripheral nerve injuries in the USA 2023 ·Journal of Comparative Effectiveness Research ·(unknown), Ann Thompson, Joseph F. Styron, Mehdi Javanbakht	8
2	Cost-effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery: Learning from 15,856 patients 2019 ·International Journal of Surgery ·Fan Yang, Simon Walker, Gerry Richardson, Tim Stephens, Mandeep Phull, Ann Thompson, Rupert M. Pearse	4
3	Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings 2013 ·Journal of Medical Economics ·Rebecca Hancock, Christopher M. Feindel, Josep Rodés‐Cabau, John G. Webb, Ann Thompson, Kurt Banz	31
4	Five-year Clinical and Economic Outcomes Among Patients With Medically Managed Severe Aortic Stenosis 2012 ·Circulation Cardiovascular Quality and Outcomes ·Mary Ann Clark, Suzanne V. Arnold, Francis G. Duhay, Ann Thompson, Michelle J. Keyes, Lars G. Svensson, Robert O. Bonow, (unknown), David J. Cohen	86
5	FIVE-YEAR CLINICAL AND ECONOMIC OUTCOMES IN PATIENTS WITH MEDICALLY MANAGED SEVERE AORTIC STENOSIS: RESULTS FROM A MEDICARE CLAIMS ANALYSIS 2011 ·Journal of the American College of Cardiology ·Mary Ann Clark, Francis G. Duhay, Ann Thompson, Michelle J. Keyes, Lars G. Svensson, Robert O. Bonow, (unknown), David J. Cohen	1
6	One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia 2008 ·Current Medical Research and Opinion ·Natalie C. Edwards, Jacqueline Pesa, Dennis Meletiche, Luella Engelhart, Ann Thompson, Jay D. Sherr, Riad Dirani	26
7	Validity of Electronically Monitored Medication Adherence and Conventional Adherence Measures in Schizophrenia 2007 ·Psychiatric Services ·Matthew Byerly, Ann Thompson, Thomas Carmody, (unknown), (unknown), Michael Kashner, A. John Rush	99
8	An Economic Comparison of Risperidone and Olanzapine Use within an Integrated Managed Mental Health Program 2005 ·Administration and Policy in Mental Health and Mental Health Services Research ·Michael Johnsrud, M. Lynn Crismon, Ann Thompson, Amy Grogg	0
9	The assessment of rheumatoid arthritis and the acceptability of self‐report questionnaires in clinical practice 2003 ·Arthritis Care & Research ·Frederick Wolfe, Theodore Pincus, Ann Thompson, Joseph Doyle	48
10	Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF‐36 2002 ·Allergy ·Elizabeth F. Juniper, Ann Thompson, Jeremy Roberts	51
11	Quality of life in patients with allergic rhinitis 2000 ·Annals of Allergy Asthma & Immunology ·Ann Thompson, Elizabeth F. Juniper, Eli O. Meltzer	149
12	Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria 2000 ·Journal of the American Academy of Dermatology ·Ann Thompson, Albert F. Finn, William F. Schoenwetter	76
13	Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial 2000 ·Arthritis & Rheumatism ·Peter Tugwell, George Wells, Vibeke Strand, Andreas Maetzel, (unknown), Bruce Crawford, (unknown), Ann Thompson	142
14	Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis 1999 ·Arthritis & Rheumatism ·Vibeke Strand, Peter Tugwell, Claire Bombardier, Andreas Maetzel, Bruce Crawford, (unknown), Ann Thompson, George A. Wells, (unknown)	111
15	Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire☆☆☆★ 1999 ·Journal of Allergy and Clinical Immunology ·Elizabeth F. Juniper, Ann Thompson, Penelope J. Ferrie, Jeremy Roberts	305
16	Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis 1999 ·Annals of Allergy Asthma & Immunology ·Eli O. Meltzer, Thomas B. Casale, Robert A. Nathan, Ann Thompson	100
17	A COMPARISON OF THE PEDIATRIC COMPREHENSIVE SEVERITY INDEX WITH THE PEDIATRIC RISK OF MORTALITY (PRISM III) SCORE 1999 ·Critical Care Medicine ·Adalberto Torres, David A. Bergman, Jay B. Dean, (unknown), Ann Thompson, David D. Wirtschafter, Stephen Johnson, Robert Pettignano, (unknown), Douglas F. Willson, (unknown), Julie Gassaway, Randall J. Smout, Susan D. Horn	2
18	ABILITY OF THE PEDIATRIC COMPREHENSIVE SEVERITY INDEX TO PREDICT LENGTH OF STAY AND COSTS 1999 ·Critical Care Medicine ·Adalberto Torres, David A. Bergman, Jay B. Dean, (unknown), Ann Thompson, David D. Wirtschafter, Stephen Johnson, Robert Pettignano, (unknown), Douglas F. Willson, (unknown), Julie Gassaway, Randall J. Smout, Susan D. Horn	2
19	Measuring quality of life in children with rhinoconjunctivitis 1998 ·Journal of Allergy and Clinical Immunology ·Elizabeth F. Juniper, William C. Howland, Natalie B. Roberts, Ann Thompson, Derek King	201
20	Traumatic Brain Injury/Chronic Pain Syndrome: A Case Comparison Study 1997 ·Clinical Journal of Pain ·Michael Andary, Nancy M. Crewe, (unknown), (unknown), (unknown), (unknown), Ann Thompson, Matheos Yosef	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact